Home https://server7.kproxy.com/servlet/redirect.srv/sruj/smyrwpoii/p2/ Business https://server7.kproxy.com/servlet/redirect.srv/sruj/smyrwpoii/p2/ FDA approves Emergency Use Authorization for COVID-19 drug combo

FDA approves Emergency Use Authorization for COVID-19 drug combo

A sign for the Food and Drug Administration will be seen outside headquarters on July 20, 2020 in White Oak, Maryland. (Photo by Sarah Silbiger / Getty Images)

TO Newsroom
UPDATED 18:45 PT – Friday 20. November 2020

The FDA issued an emergency use approval for a drug combination with coronavirus for the treatment of moderate and severely ill patients.

FDA Commissioner Dr. Stephen M. Hahn said this action demonstrates the agency’s firm efforts to make potential coronavirus treatments available in a timely manner.

On Thursday, the FDA approved the mixture of ‘remdesevir’ and rheumatoid arthritis ‘baricitinib’. This came after studies showed that the drug combination shortened the recovery time for COVID-19 to approx. one week.

According to a double-blind trial, the combination also increased the chances of survival by 35 percent compared to patients who only took ‘remdesivir’.

MORE NEWS: Trump campaign: Americans do not trust mainstream media election coverage

Source link